Domů › Rakovina (všechny typy) › Texas › Austin
Klinické studie Rakovina (všechny typy) v Austin, TX
20 studií pro Rakovina (všechny typy) hledá účastníky v lokalitách v Austin a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Probíhá náborFáze 2
- Texas Oncology-Austin North /ID# 279958, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Probíhá náborFáze 3
- Texas Oncology, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Probíhá náborFáze 1
- NEXT Oncology, Austin
Prospective Study to Assess a Diagnostic Aid for Cancer
Probíhá náborObservační studie
- Premier Family Physicians, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Probíhá náborFáze 2
- Dell Medical School, University of Texas at Austin, Austin
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Probíhá náborFáze 1/2
- NEXT Oncology ( Site 1010), Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Probíhá náborFáze 1
- NEXT Oncology - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Probíhá náborFáze 3
- USO - Texas Oncology, Austin
Project: Every Child for Younger Patients With Cancer
Probíhá náborObservační studie
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 1
- Texas Oncology - Central/South Texas /ID# 268563, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Probíhá náborFáze 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Probíhá náborFáze 2/3
- Texas Oncology - South Austin /ID# 276033, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Probíhá náborFáze 2
- Texas Oncology - Austin Central, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Probíhá náborFáze 1
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Probíhá náborFáze 1
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Probíhá náborFáze 1/2
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Probíhá náborFáze 1/2
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
Probíhá náborFáze 1/2
- NEXT Oncology Austin, Austin
Studie Rakovina (všechny typy) v jiných městech
- Houston, TX121 studií
- New York City, NY110 studií
- Boston, MA86 studií
- Los Angeles, CA73 studií
- Nashville, TN65 studií
- Philadelphia, PA59 studií
- Durham, NC58 studií
- Washington, DC58 studií
- Chicago, IL51 studií
- Seattle, WA49 studií
- Atlanta, GA49 studií
- Arlington, VA48 studií
Další studie v Austin
- Nemalobuněčný plicní karcinom30 studií
- Obesity20 studií
- Metastatický karcinom19 studií
- Kolorektální karcinom19 studií
- Srdeční selhání18 studií
- Rakovina prsu18 studií
- Nadváha18 studií
- Rakovina vaječníků17 studií
- Rakovina endometria15 studií
- Rakovina prostaty15 studií
- Deprese14 studií
- Trojně negativní rakovina prsu13 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.